製品: Phospho-MYPT1 (Ser472) Antibody
カタログ: AF3779
タンパク質の説明: Rabbit polyclonal antibody to Phospho-MYPT1 (Ser472)
アプリケーション: WB
Cited expt.: WB
反応性: Human, Mouse, Rat
分子量: 115kD(Calculated).
ユニプロット: O14974
RRID: AB_2847093

類似製品を見る>>

   サイズ 価格 在庫状況
 100ul $350 在庫あり
 200ul $450 在庫あり

リードタイム: 当日配達

For pricing and ordering contact:
お問い合わせ先

製品説明

ソース:
Rabbit
アプリケーション:
WB 1:500-1:2000
*The optimal dilutions should be determined by the end user.
*Tips:

WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.

反応性:
Human,Mouse,Rat
クローナリティ:
Polyclonal
特異性:
Phospho-MYPT1 (Ser472) Antibody detects endogenous levels of MYPT1 only when phosphorylated at Ser472.
RRID:
AB_2847093
引用形式: Affinity Biosciences Cat# AF3779, RRID:AB_2847093.
コンジュゲート:
Unconjugated.
精製:
The antibody is from purified rabbit serum by affinity purification via sequential chromatography on phospho-peptide and non-phospho-peptide affinity columns.
保存:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
別名:

折りたたみ/展開

M130; MBS; Myosin binding subunit; Myosin phosphatase target subunit 1; Myosin phosphatase targeting subunit 1; Myosin phosphatase-targeting subunit 1; MYPT1; MYPT1_HUMAN; PPP1R12A; Protein phosphatase 1 regulatory inhibitor subunit 12A; Protein phosphatase 1 regulatory subunit 12A; Protein phosphatase 1, regulatory (inhibitor) subunit 12A; Protein phosphatase myosin binding subunit; Protein phosphatase myosin-binding subunit;

免疫原

免疫原:

A synthesized peptide derived from human MYPT1 around the phosphorylation site of Ser472.

Uniprot:
遺伝子(ID):
発現特異性:
O14974 MYPT1_HUMAN:

Expressed in striated muscles, specifically in type 2a fibers (at protein level).

タンパク質配列:
MKMADAKQKRNEQLKRWIGSETDLEPPVVKRQKTKVKFDDGAVFLAACSSGDTDEVLKLLHRGADINYANVDGLTALHQACIDDNVDMVKFLVENGANINQPDNEGWIPLHAAASCGYLDIAEFLIGQGAHVGAVNSEGDTPLDIAEEEAMEELLQNEVNRQGVDIEAARKEEERIMLRDARQWLNSGHINDVRHAKSGGTALHVAAAKGYTEVLKLLIQAGYDVNIKDYDGWTPLHAAAHWGKEEACRILVDNLCDMEMVNKVGQTAFDVADEDILGYLEELQKKQNLLHSEKRDKKSPLIESTANMDNNQSQKTFKNKETLIIEPEKNASRIESLEQEKVDEEEEGKKDESSCSSEEDEEDDSESEAETDKTKPLASVTNANTSSTQAAPVAVTTPTVSSGQATPTSPIKKFPTTATKISPKEEERKDESPATWRLGLRKTGSYGALAEITASKEGQKEKDTAGVTRSASSPRLSSSLDNKEKEKDSKGTRLAYVAPTIPRRLASTSDIEEKENRDSSSLRTSSSYTRRKWEDDLKKNSSVNEGSTYHKSCSFGRRQDDLISSSVPSTTSTPTVTSAAGLQKSLLSSTSTTTKITTGSSSAGTQSSTSNRLWAEDSTEKEKDSVPTAVTIPVAPTVVNAAASTTTLTTTTAGTVSSTTEVRERRRSYLTPVRDEESESQRKARSRQARQSRRSTQGVTLTDLQEAEKTIGRSRSTRTREQENEEKEKEEKEKQDKEKQEEKKESETSREDEYKQKYSRTYDETYQRYRPVSTSSSTTPSSSLSTMSSSLYASSQLNRPNSLVGITSAYSRGITKENEREGEKREEEKEGEDKSQPKSIRERRRPREKRRSTGVSFWTQDSDENEQEQQSDTEEGSNKKETQTDSISRYETSSTSAGDRYDSLLGRSGSYSYLEERKPYSSRLEKDDSTDFKKLYEQILAENEKLKAQLHDTNMELTDLKLQLEKATQRQERFADRSLLEMEKRERRALERRISEMEEELKMLPDLKADNQRLKDENGALIRVISKLSK

研究背景

機能:

Key regulator of protein phosphatase 1C (PPP1C). Mediates binding to myosin. As part of the PPP1C complex, involved in dephosphorylation of PLK1. Capable of inhibiting HIF1AN-dependent suppression of HIF1A activity.

PTMs:

Phosphorylated by CIT (Rho-associated kinase) (By similarity). Phosphorylated cooperatively by ROCK1 and CDC42BP on Thr-696. Phosphorylated on upon DNA damage, probably by ATM or ATR. In vitro, phosphorylation of Ser-695 by PKA and PKG appears to prevent phosphorylation of the inhibitory site Thr-696, probably mediated by PRKG1. Phosphorylation at Ser-445, Ser-472 and Ser-910 by NUAK1 promotes interaction with 14-3-3, leading to inhibit interaction with myosin light chain MLC2, preventing dephosphorylation of MLC2. May be phosphorylated at Thr-696 by DMPK; may inhibit the myosin phosphatase activity. Phosphorylated at Ser-473 by CDK1 during mitosis, creating docking sites for the POLO box domains of PLK1. Subsequently, PLK1 binds and phosphorylates PPP1R12A.

細胞の位置付け:

Cytoplasm. Cytoplasm>Cytoskeleton>Stress fiber.
Note: Also along actomyosin filaments.

Extracellular region or secreted Cytosol Plasma membrane Cytoskeleton Lysosome Endosome Peroxisome ER Golgi apparatus Nucleus Mitochondrion Manual annotation Automatic computational assertionSubcellular location
組織特異性:

Expressed in striated muscles, specifically in type 2a fibers (at protein level).

タンパク質ファミリー:

Heterotetramerization is mediated by the interaction between a coiled-coil of PRKG1 and the leucine/isoleucine zipper of PPP1R12A/MBS, the myosin-binding subunit of the myosin phosphatase.

The KVKF motif mediates interaction with PPP1CB.

研究領域

· Cellular Processes > Cellular community - eukaryotes > Focal adhesion.   (View pathway)

· Cellular Processes > Cell motility > Regulation of actin cytoskeleton.   (View pathway)

· Environmental Information Processing > Signal transduction > cGMP-PKG signaling pathway.   (View pathway)

· Environmental Information Processing > Signal transduction > cAMP signaling pathway.   (View pathway)

· Human Diseases > Cancers: Overview > Proteoglycans in cancer.

· Organismal Systems > Circulatory system > Vascular smooth muscle contraction.   (View pathway)

· Organismal Systems > Immune system > Platelet activation.   (View pathway)

· Organismal Systems > Endocrine system > Oxytocin signaling pathway.

参考文献

1). AMPK is a mechano-metabolic sensor linking cell adhesion and mitochondrial dynamics to Myosin-dependent cell migration. Nature Communications, 2023 (PubMed: 37217519) [IF=16.6]

Application: WB    Species: Human    Sample: A375P cells

Fig. 4: ATP levels control plasticity of cell migration through AMPK. a AMP, ATP/AMP and ATP/ADP in A375P cells treated with rotenone (0.5 μM) and antimycin A (0.5 μM) (5 replicates/condition). b Western blot for the same conditions as in (a). c Western blot of the indicated proteins (WM983 n = 6, A375 n = 5). d Western blot upon AMPK knock-down (n = 3). e Cells grown on a collagen I matrix. Immunofluorescence images showing pMLC2 (green) and F-actin (red) (n = 3). Scale bar = 5 μm. f–h Quantification of cell morphology (211, 193 cells pooled from n = 3) (f), pMLC2 immunofluorescence signal normalized by cell area (52, 66 cells pooled from n = 3) (g) and representative traction stress (n = 3). Colour bar indicates traction stress magnitude (Pascal, Pa), scale bar = 20 μm (h). i Western blot upon AMPK activation (A769662 10 μM, 30 minutes) (n = 5). j–l Cells grown on a collagen I matrix. Immunofluorescence images showing pMLC2 (green) and F-actin (red) after A769662 treatment (10 μM, 24 h) (n = 3), scale bar = 10 μm (j); quantification of cell morphology (317, 283 cells pooled from n = 3) (k) and quantification of pMLC2 immunofluorescence signal normalized by cell area (81, 84 cells pooled from n = 3) (l). m, n Western blot and quantification after DDR1 knock-down and Comp C treatment (2 μM, 24 h) (n = 8 AMPK, n = 6 ACC, n = 9 MYPT1). o–q Cells grown on a collagen I matrix. Immunofluorescence images showing pMLC2 (green) and F-actin (red) (n = 3), scale bar = 10 μm (o); quantification of cell morphology (274, 210, 274, 191 cells pooled from n = 3) (p) and quantification of pMLC2 immunofluorescence signal normalized by cell area (93, 84, 94, 93 cells pooled from n = 3) (q). Quantification versus corresponding total protein (b, c, d, i). Graphs (a, n) show mean ± SEM. Violin plots (f, k, p) show median with interquartile range. Box plots (g, l, q) show median (centre line), interquartile range (box) and min-max values (whiskers). p values were calculated using two-tailed tests (f, g, k, l). p value by Mann–Whitney test (f, g, k, l), one-way ANOVA with Dunnett’s correction (a) or Tukey’s multiple test (n) and Kruskal-Wallis with Dunn’s multiple comparisons test (p, q). All n are indicative of independent experiments unless otherwise stated. Source data are provided as a Source Data file.

Application: WB    Species: Human    Sample: A375P cells

Fig. 4: ATP levels control plasticity of cell migration through AMPK. a AMP, ATP/AMP and ATP/ADP in A375P cells treated with rotenone (0.5 μM) and antimycin A (0.5 μM) (5 replicates/condition). b Western blot for the same conditions as in (a). c Western blot of the indicated proteins (WM983 n = 6, A375 n = 5). d Western blot upon AMPK knock-down (n = 3). e Cells grown on a collagen I matrix. Immunofluorescence images showing pMLC2 (green) and F-actin (red) (n = 3). Scale bar = 5 μm. f–h Quantification of cell morphology (211, 193 cells pooled from n = 3) (f), pMLC2 immunofluorescence signal normalized by cell area (52, 66 cells pooled from n = 3) (g) and representative traction stress (n = 3). Colour bar indicates traction stress magnitude (Pascal, Pa), scale bar = 20 μm (h). i Western blot upon AMPK activation (A769662 10 μM, 30 minutes) (n = 5). j–l Cells grown on a collagen I matrix. Immunofluorescence images showing pMLC2 (green) and F-actin (red) after A769662 treatment (10 μM, 24 h) (n = 3), scale bar = 10 μm (j); quantification of cell morphology (317, 283 cells pooled from n = 3) (k) and quantification of pMLC2 immunofluorescence signal normalized by cell area (81, 84 cells pooled from n = 3) (l). m, n Western blot and quantification after DDR1 knock-down and Comp C treatment (2 μM, 24 h) (n = 8 AMPK, n = 6 ACC, n = 9 MYPT1). o–q Cells grown on a collagen I matrix. Immunofluorescence images showing pMLC2 (green) and F-actin (red) (n = 3), scale bar = 10 μm (o); quantification of cell morphology (274, 210, 274, 191 cells pooled from n = 3) (p) and quantification of pMLC2 immunofluorescence signal normalized by cell area (93, 84, 94, 93 cells pooled from n = 3) (q). Quantification versus corresponding total protein (b, c, d, i). Graphs (a, n) show mean ± SEM. Violin plots (f, k, p) show median with interquartile range. Box plots (g, l, q) show median (centre line), interquartile range (box) and min-max values (whiskers). p values were calculated using two-tailed tests (f, g, k, l). p value by Mann–Whitney test (f, g, k, l), one-way ANOVA with Dunnett’s correction (a) or Tukey’s multiple test (n) and Kruskal-Wallis with Dunn’s multiple comparisons test (p, q). All n are indicative of independent experiments unless otherwise stated. Source data are provided as a Source Data file.

2). AMPK is a Mechano-Metabolic Sensor Linking Mitochondrial Dynamics to Myosin II Dependent Cell Migration. , 2021

3). AMPK is a mechano-metabolic sensor linking cell adhesion and mitochondrial dynamics to Myosin II dependent cell migration. , 2022

Application: WB    Species: Mouse    Sample: WM983B and A375M2 cells

Figure 4: Energy levels control plasticity of cell migration through AMPK signalling. A-B) Western blot (A) and quantification (B) of AMPK and MYPT1 phosphorylation in rounded-amoeboid versus elongated-mesenchymal cells (n=3). C) Upon AMPK inhibition (Compound C (Comp C) 2 mM, 24 hours) in WM983B and A375M2 cells, western blot showing levels of AMPK and MYPT1 phosphorylation (n=3). Quantification normalized by total AMPK and MYPT1, respectively. D) Cells grown on a collagen I matrix. Immunofluorescence images showing pMLC2 (green) and F-actin (red) after Comp C treatment (2 mM, 24 hours). Scale bar = 10 mm. E-F) After Comp C treatment, quantification of cell morphology (>200 cells pooled from 3 experiments) (E) and quantification of pMLC2 immunofluorescence signal normalized by cell area (>90 cells pooled from 3 experiments) (F). G) Upon AMPK activation (A769662 10 mM, 30 minutes) in WM983A and A375P cells, western blot showing levels of AMPK and MYPT1 phosphorylation (n=3). Quantification normalized by total AMPK and MYPT1, respectively. H) Cells grown on a collagen I matrix. Immunofluorescence images showing pMLC2 (green) and F-actin (red) after A769662 treatment (10 mM, 24 hours). Scale bar = 10 mm. I-J) After A769662 treatment, quantification of cell morphology (>200 cells pooled from 3 experiments) (I) and quantification of pMLC2 immunofluorescence signal normalized by cell area (>90 cells pooled from 3 experiments) (J). K-L) Western blot (K) and quantification (L) of AMPK and MYPT1 phosphorylation levels after DDR1 knockdown and treatment with Comp C (2 mM, 24 hours) in A375P cells (n=3). M) Cells grown on a collagen I matrix. Immunofluorescence images showing pMLC2 (green) and F-actin (red) after DDR1 knock-down and Comp C treatment (2 mM, 24 hours). Scale bar = 10 mm. N-O) After DDR1 knock-down and Comp C treatment, quantification of cell morphology (>200 cells pooled from 3 experiments) (N) and quantification of pMLC2 immunofluorescence signal normalized by cell area (>90 cells pooled from 3 experiments) (O). Graphs (B, L) show mean ± SEM. Dot plots (E, I, N) show median with interquartile range (each dot represents a single cell). Box plots (F, J, O) show min to max. p value by paired t-test (B), Mann-Whitney test (E, F, I, J), one-way ANOVA with Dunnett’s correction (L) and Kruskal-Wallis with Dunn’s multiple comparisons test (N, O). For all graphs, *p

Restrictive clause

 

Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.

For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.